Healthcare strength, buyers retake control
Eli Lilly gains 6.4% as buyers retake control
Our view last week
After last week's bounce, sellers have taken back control of Eli Lilly: 87% of the week's volume traded on the sell side, money flow flipped negative, and the MACD histogram has now fallen for a fourth straight week. The stock is still hugging its highs though, boxed in between the 1182 resistance area and the 1177 support area, with the trade still up 17.44% from entry.
This week's summary
Eli Lilly closes the week up 6.4%, with buyers firmly back in control after the prior week's selling. The stock is hugging its all-time highs, supported by a Health Care sector in strong shape. The trade, open for 14 weeks, shows a 24.93% profit and has already completed the model's coverage: the stop now trails the Inversion Point, protecting the gain.
IQS Phase
72
in tension
Signal Strength
66
medium
Sizing
STANDARD
Ranking
#35 / 167
US stocks in progress
Trade P&L %
+24.93%
from signal to date, no stop loss
Rank position
ranks 35th among the 167 Longs already running for US stocks in our ranking, with a signal strength of 66 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein strong phase
Performanceweekly +4.33% · monthly +9.53%
LLY belongs to the health care sector (reference ETF XLV). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content